ArticlePharmacology research & perspectives2022

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018.

David B Finlay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.